218 related articles for article (PubMed ID: 16421164)
1. Aberrant expression of SPARC and its impact on proliferation and apoptosis in ADPKD cyst-lining epithelia.
Wang W; Mei C; Tang B; Zhao H; Xu C; Li Z; Shen X; Fu W; Dai B
Nephrol Dial Transplant; 2006 May; 21(5):1278-88. PubMed ID: 16421164
[TBL] [Abstract][Full Text] [Related]
2. Role of keratinocyte growth factor in the pathogenesis of autosomal dominant polycystic kidney disease.
Mei C; Mao Z; Shen X; Wang W; Dai B; Tang B; Wu Y; Cao Y; Zhang S; Zhao H; Sun T
Nephrol Dial Transplant; 2005 Nov; 20(11):2368-75. PubMed ID: 16141466
[TBL] [Abstract][Full Text] [Related]
3. Autocrine, endocrine and paracrine regulation of growth abnormalities in autosomal dominant polycystic kidney disease.
Wilson PD; Du J; Norman JT
Eur J Cell Biol; 1993 Jun; 61(1):131-8. PubMed ID: 8223698
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of osteonectin by human retinal pigment epithelial cells is modulated by cell density.
Magee RM; Hagan S; Hiscott PS; Sheridan CM; Carron JA; McGalliard J; Grierson I
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2707-11. PubMed ID: 10937587
[TBL] [Abstract][Full Text] [Related]
5. Secretion of cytokines and growth factors into autosomal dominant polycystic kidney disease liver cyst fluid.
Nichols MT; Gidey E; Matzakos T; Dahl R; Stiegmann G; Shah RJ; Grantham JJ; Fitz JG; Doctor RB
Hepatology; 2004 Oct; 40(4):836-46. PubMed ID: 15382115
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of cellular proliferation and apoptosis mediates human autosomal dominant polycystic kidney disease (ADPKD).
Lanoix J; D'Agati V; Szabolcs M; Trudel M
Oncogene; 1996 Sep; 13(6):1153-60. PubMed ID: 8808689
[TBL] [Abstract][Full Text] [Related]
7. Autosomal dominant polycystic kidney disease: clinical and genetic aspects.
Sessa A; Ghiggeri GM; Turco AE
J Nephrol; 1997; 10(6):295-310. PubMed ID: 9442442
[TBL] [Abstract][Full Text] [Related]
8. Rosiglitazone inhibits cell proliferation by inducing G1 cell cycle arrest and apoptosis in ADPKD cyst-lining epithelia cells.
Liu Y; Dai B; Fu L; Jia J; Mei C
Basic Clin Pharmacol Toxicol; 2010 Jun; 106(6):523-30. PubMed ID: 20210794
[TBL] [Abstract][Full Text] [Related]
9. Haploinsufficiency of Pkd2 is associated with increased tubular cell proliferation and interstitial fibrosis in two murine Pkd2 models.
Chang MY; Parker E; Ibrahim S; Shortland JR; Nahas ME; Haylor JL; Ong AC
Nephrol Dial Transplant; 2006 Aug; 21(8):2078-84. PubMed ID: 16720597
[TBL] [Abstract][Full Text] [Related]
10. Implication of TNF-related apoptosis-inducing ligand in inflammatory intestinal epithelial lesions.
Begue B; Wajant H; Bambou JC; Dubuquoy L; Siegmund D; Beaulieu JF; Canioni D; Berrebi D; Brousse N; Desreumaux P; Schmitz J; Lentze MJ; Goulet O; Cerf-Bensussan N; Ruemmele FM
Gastroenterology; 2006 Jun; 130(7):1962-74. PubMed ID: 16762619
[TBL] [Abstract][Full Text] [Related]
11. Gene profiling of polycystic kidneys.
Schieren G; Rumberger B; Klein M; Kreutz C; Wilpert J; Geyer M; Faller D; Timmer J; Quack I; Rump LC; Walz G; Donauer J
Nephrol Dial Transplant; 2006 Jul; 21(7):1816-24. PubMed ID: 16520345
[TBL] [Abstract][Full Text] [Related]
12. Differential effect of Cyclosporin A and FK506 on SPARC mRNA expression by human gingival fibroblasts.
Gagliano N; Moscheni C; Torri C; Dellavia C; Stabellini G; Ferrario VF; Gioia M
Biomed Pharmacother; 2005 Jun; 59(5):249-52. PubMed ID: 15890490
[TBL] [Abstract][Full Text] [Related]
13. The differential expression of SPARC in esophageal squamous cell carcinoma.
Che Y; Luo A; Wang H; Qi J; Guo J; Liu Z
Int J Mol Med; 2006 Jun; 17(6):1027-33. PubMed ID: 16685412
[TBL] [Abstract][Full Text] [Related]
14. Abnormal extracellular matrix and excessive growth of human adult polycystic kidney disease epithelia.
Wilson PD; Hreniuk D; Gabow PA
J Cell Physiol; 1992 Feb; 150(2):360-9. PubMed ID: 1734038
[TBL] [Abstract][Full Text] [Related]
15. Pax2 gene dosage influences cystogenesis in autosomal dominant polycystic kidney disease.
Stayner C; Iglesias DM; Goodyer PR; Ellis L; Germino G; Zhou J; Eccles MR
Hum Mol Genet; 2006 Dec; 15(24):3520-8. PubMed ID: 17082250
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of secreted protein acidic and rich in cystein in esophageal carcinoma and its relation to carcinoma progression.
Yamashita K; Upadhay S; Mimori K; Inoue H; Mori M
Cancer; 2003 May; 97(10):2412-9. PubMed ID: 12733139
[TBL] [Abstract][Full Text] [Related]
17. Pkd1 regulates immortalized proliferation of renal tubular epithelial cells through p53 induction and JNK activation.
Nishio S; Hatano M; Nagata M; Horie S; Koike T; Tokuhisa T; Mochizuki T
J Clin Invest; 2005 Apr; 115(4):910-8. PubMed ID: 15761494
[TBL] [Abstract][Full Text] [Related]
18. An in vitro model of posterior capsular opacity: SPARC and TGF-beta2 minimize epithelial-to-mesenchymal transition in lens epithelium.
Gotoh N; Perdue NR; Matsushima H; Sage EH; Yan Q; Clark JI
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4679-87. PubMed ID: 17898292
[TBL] [Abstract][Full Text] [Related]
19. The expression of SPARC in adipose tissue and its increased plasma concentration in patients with coronary artery disease.
Takahashi M; Nagaretani H; Funahashi T; Nishizawa H; Maeda N; Kishida K; Kuriyama H; Shimomura I; Maeda K; Hotta K; Ouchi N; Kihara S; Nakamura T; Yamashita S; Matsuzawa Y
Obes Res; 2001 Jul; 9(7):388-93. PubMed ID: 11445660
[TBL] [Abstract][Full Text] [Related]
20. Depletion of PKD1 by an antisense oligodeoxynucleotide induces premature G1/S-phase transition.
Kim H; Bae Y; Jeong W; Ahn C; Kang S
Eur J Hum Genet; 2004 Jun; 12(6):433-40. PubMed ID: 15054393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
